Blockchain Registration Transaction Record
Sigyn Therapeutics, Inc. Appoints Michael Ryan to Board of Directors
Sigyn Therapeutics, Inc. appoints Michael Ryan, an experienced executive, to its Board of Directors. Ryan's expertise in technology and life sciences will contribute to the development of life-saving blood purification technologies, addressing critical global health challenges.
This news matters as it highlights the strategic move by Sigyn Therapeutics to enhance its leadership team with the appointment of Michael Ryan. Ryan's experience and expertise will play a crucial role in advancing the development of innovative blood purification technologies that have the potential to save lives and address critical global health challenges.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x3f1a9f082541499c2ba20adfc64edb3c21d971a9c517fabe0498d9c2823a9b76 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fondrMUd-f83b80f094ad243636fcf39f452359e5 |